Spasticity is a commonly encountered phenomenon in patients who have sustained an upper motor neuron injury. There are a plethora of potential interventions for spasticity reduction including oral, injectable, and intrathecal medications. Each of these techniques has associated advantages and disadvantages. The purpose of this course will be to describe the subtleties and controversies regarding spasticity management. Multiple medical specialists would find this course of interest including neurology, neurosurgery, anesthesiology, and physical medicine and rehabilitation. This session will also be of interest to many allied health professionals such as physical therapy, occupational therapy, nursing, pharmacy, case management, and bioengineering.
Upon completion of this educational activity, participants should be able to:
- Explain the potential role of phenol injections for spasticity management.
- Describe the most recent development in the use of botulinum toxin injections for spasticity management.
- Review the most current concept regarding intrathecal drug delivery for spasticity management including medications other than baclofen and novel dosing strategies.
The Role of Phenol Injections in Spasticity Management
Sheng Li, MD PhD
Future Directions in Botulinum Toxin Therapy
Monica Verduzco-Gutierrez, MD
Novel Strategies for Intrathecal Baclofen Dosing
Jay M. Meythaler, MD
Exploring Other Intrathecal Medications for Spasticity Management
Lake Wendell, MD
Faculty and Presentations subject to change.